Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis

ZEITSCHRIFT FUR RHEUMATOLOGIE(2013)

引用 23|浏览9
暂无评分
关键词
ankylosing spondylitis,spinal inflammation,secukinumab leads,unchanged fatty lesions
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要